SCHEMBL8032685

SCHEMBL8032685

N#Cc1cccc(CSc2nc(Cl)c(C#N)c(-c3ccc(CCCO)cc3)c2C#N)c1

nearest known ligand 0.49

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 17/20 0.49
ADORA2A P29274 2/20 0.49
ADORA3 P0DMS8 1/20 0.49
ADORA2B P29275 3/20 0.44
RET P07949 2/20 0.42
ACMSD Q8TDX5 1/20 0.41
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10194179 0.87 ADORA1 (0.64) ADORA1ADORA2AADORA3ADORA2BACMSD
SCHEMBL12945818 0.86 ADORA1 (0.55) ADORA1ADORA2AADORA3ADORA2BSLC6A3
SCHEMBL10193889 0.79 ADORA1 (0.49) ADORA1ADORA2AADORA3ADORA2B
SCHEMBL10194487 0.78 ADORA1 (0.77) ADORA1ADORA2AADORA3ADORA2BRET
SCHEMBL13914380 0.77 ADORA1 (0.72) ADORA1ADORA2AADORA3ADORA2BRET
SCHEMBL8034134 0.77 ADORA1 (0.63) ADORA1ADORA2AADORA3ADORA2BSLC6A3
SCHEMBL13914360 0.77 ADORA1 (0.67) ADORA1ADORA2AADORA3ADORA2BRET
SCHEMBL7900477 0.77 ADORA1 (0.66) ADORA1RETSLC6A3
SCHEMBL12910821 0.77 ADORA1 (0.49) ADORA1ADORA2AADORA3ADORA2BSLC6A3
SCHEMBL251890 0.76 ALDH1A1 (0.62) ADORA1ADORA2AADORA3ADORA2BRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2235011-B1 SUBSTITUTED PYRROLO[2, 3-B]AND PYRAZOLO[3, 4-B]PYRIDINES FOR USE AS ADENOSINE RECEPTOR LIGANDS Bayer Pharma AG (DE) 2012-01-25 EP disclosed
WO-2009080197-A1 SUBSTITUTED PYRROLO[2, 3-B] AND PYRAZOLO[3, 4-B] PYRIDINES FOR USE AS ADENOSINE RECEPTOR LIGANDS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed